Relapsing after quitting cocaine is not simply a matter of willpower — it reflects physical changes in the brain, according to new research. Scientists have found that repeated cocaine use reshapes ...

Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process ...

Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring and impulse control, not drug-specific traits.

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

GLP-1 medications like semaglutide (Ozempic) may offer unexpected mental health benefits alongside weight loss. A large study found major drops in depression, anxiety, and psychiatric-related hospital ...

A mouse study highlights the role of acetylcholine in behavioral flexibility, offering new insight into the brain mechanisms involved in addiction and obsessive compulsive disorder.

Smoking among youngsters is a growing public health concern, driven by peer pressure, curiosity, stress, and social media ...

People taking GLP-1 drugs often talk about “food noise” vanishing: the constant mental chatter about food that dominated thei ...

At the launch of the Gambling Support Service for Mayo, hosted by Tacú Family Resource Centre in Ballinrobe in partnership ...

Engagement-maximizing architectures such as infinite scroll, autoplay, and emotionally targeted notifications remain broadly permissible. That gap, however, is now being challenged on multiple fronts.

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...